- You are here:
- Home »
- Blog »
- esophageal cancer »
- Enhance ICI Response in Gastroesophageal Cancer
Enhance ICI Response in Gastroesophageal Cancer
How can you enhance ICI response in gastroesophageal cancer? ICI’s have shown a remarkable ability to treat GEC patients. But according to the research below, emotional distress has been demonstrated to compromise immune responses.
Let’s face it. What newly diagnosed EC patient is not emotionally distressed?
I am a long-term survivor of a blood cancer called multiple myeloma. I believe the mind can have a profound effect, both positive and negative, on the cancer patient. The question is how to manage this profound effect.
But frankly, I don’t know exactly what “emotionally distressed” means. I do, however, understand how our gut microbiome can affect our mental health and how immune checkpoint inhibitors can respond in patients.
How Your Gut Bacteria Controls Your Mood
Here’s a 7-day, microbiome-supportive menu designed specifically for a cancer patient preparing to start immune checkpoint inhibitors (ICIs). The goal is to increase microbial diversity, short-chain fatty acid production, and gut barrier integrity, all of which are associated with better ICI response and fewer immune-related adverse events (irAEs).
Core principles behind the menu
-
High fiber diversity (≥25–35 g/day from many plant sources)
-
Fermented foods (live cultures, small daily doses)
-
Polyphenol-rich foods (berries, olive oil, cocoa, herbs)
-
Omega-3 fats (anti-inflammatory immune modulation)
-
Minimal ultra-processed foods, added sugars, and emulsifiers
Day 1
Breakfast
-
Steel-cut oats cooked with almond milk
-
Blueberries + ground flaxseed
-
Green tea
Lunch
-
Lentil, carrot, and leek soup
-
Side of sauerkraut (2–3 Tbsp)
-
Whole-grain sourdough
Snack
-
Apple slices with almond butter
Dinner
-
Baked salmon with olive oil and dill
-
Quinoa
-
Steamed broccoli + garlic
Day 2
Breakfast
-
Plain Greek yogurt or coconut yogurt (unsweetened)
-
Walnuts, raspberries, chia seeds
Lunch
-
Chickpea, cucumber, tomato, parsley salad
-
Olive oil + lemon dressing
Snack
-
Kefir (½–1 cup) or kombucha (low sugar)
Dinner
-
Roasted chicken or tempeh
-
Sweet potato
-
Sautéed kale with onions
Day 3
Breakfast
-
Smoothie: spinach, banana, frozen berries, flax, oat milk
Lunch
-
Miso soup with tofu and seaweed
-
Brown rice
-
Kimchi (small serving)
Snack
-
Pear + handful of pistachios
Dinner
-
Baked cod or lentil loaf
-
Barley pilaf
-
Roasted Brussels sprouts
Day 4
Breakfast
-
Buckwheat pancakes
-
Plain yogurt + strawberries
Lunch
-
Black bean and avocado bowl
-
Brown rice, cilantro, lime
Snack
-
Dark chocolate (70–85%, 1–2 squares)
Dinner
-
Turkey meatballs or mushroom balls
-
Tomato-rich marinara
-
Whole-grain pasta
-
Side salad with olive oil
Day 5
Breakfast
-
Overnight oats with kefir
-
Chopped apple, cinnamon, walnuts
Lunch
-
Mediterranean lentil salad (lentils, arugula, olives, red onion)
Snack
-
Hummus with carrots and celery
Dinner
-
Grilled sardines or baked tofu
-
Farro
-
Roasted zucchini and peppers
Day 6
Breakfast
-
Scrambled eggs or chickpea scramble
-
Sautéed mushrooms and spinach
-
Sourdough toast
Lunch
-
Vegetable minestrone (beans, onions, garlic, herbs)
Snack
-
Kombucha or yogurt with berries
Dinner
-
Slow-cooked chicken or lentil stew
-
Root vegetables (parsnip, carrot, onion)
-
Side of fermented pickles
Day 7
Breakfast
-
Smoothie bowl: kefir, berries, cacao nibs, chia
Lunch
-
Wild rice salad with cranberries, pecans, herbs
Snack
-
Kiwi + pumpkin seeds
Dinner
-
Grilled salmon or chickpea patties
-
Mashed cauliflower with olive oil
-
Steamed asparagus
Optional daily add-ons (if tolerated)
-
Extra-virgin olive oil: 1–2 Tbsp/day
-
Herbs & spices: turmeric, ginger, rosemary, oregano
-
Prebiotic fibers: oats, onions, garlic, leeks, asparagus
-
Hydration: water, green tea, herbal teas
Important ICI-specific notes
-
Avoid unnecessary antibiotics unless medically required (strongly linked to poorer ICI response)
-
Introduce fermented foods gradually to avoid bloating
-
If history of colitis or IBS, fiber may need slower escalation
-
During active immune-related colitis, this plan may need modification
Enhancing your gut microbiome may be able to manage your emotional distress while it enhances the efficacy of immune checkpoint inhibitors.
Please scroll down the page, post a question or comment and I will reply to you ASAP.
Good luck,
David Emerson
- Cancer Survivor
- Cancer Coach
- Director PeopleBeatingCancer
Pretreatment emotional distress and peripheral biomarkers predict immune checkpoint inhibitor response in people with advanced inoperable gastroesophageal cancer
Abstract
Background
Emotional distress (ED) has been demonstrated to compromise immune responses against tumors; however, few clinical studies have explored its influence on the efficacy of immune checkpoint inhibitors (ICIs) in cancer patients, especially those with gastroesophageal cancer (GEC). Additionally, reliable biomarkers for predicting the response to immunotherapy remain elusive. This study was aimed at investigating whether ED affects the outcomes of immunotherapy in advanced GEC patients and identifying potential biomarkers predictive of immunotherapy efficacy.
Methods
This prospective observational cohort study enrolled 84 patients with advanced, treatment-naïve, and inoperable GEC. ED was evaluated at baseline using the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder 7-item Scale. The primary endpoint was Progression-Free Survival (PFS), while the secondary endpoint was Disease Control Rate (DCR).
Results
Patients with baseline ED exhibit significantly shorter median PFS (7.8 months vs. 14.0 months, HR = 2.59, 95% CI: 1.35-4.97, P = 0.004) and a lower DCR (39.5% vs. 68.3%, OR = 3.21, 95% CI: 1.29–7.98, P = 0.012) compared to those without ED. Exploratory analyses further demonstrate that both pre- and post-treatment peripheral inflammatory markers (PIMs) are independently and jointly associated with survival outcomes in combination with ED.
Conclusions
This prospective study demonstrates that ED and elevated PIMs significantly impair ICI efficacy in advanced GEC. The synergistic interaction between ED and PIMs suggests underlying psycho-inflammatory mechanisms affecting treatment outcomes. These findings establish the clinical importance of integrating routine psychological assessment and PIMs monitoring in cancer patients receiving immunotherapy.
Plain language summary
This study explored how stress and inflammation affect treatment outcomes in patients with advanced stomach or esophageal cancer receiving a type of treatment called immunotherapy. We aimed to understand why some patients respond better to these drugs and whether emotional health plays a role. We followed 84 patients, using questionnaires and blood tests to measure stress and inflammation before treatment. Patients with high stress before treatment saw faster cancer progression (7.8 vs. 14 months) and poorer responses to immunotherapy. High inflammation levels further worsened outcomes, especially when combined with stress. These results highlight that reducing stress and monitoring inflammation before treatment could help doctors tailor immunotherapy plans, potentially improving survival and quality of life for cancer patients…
enhance ICI response in gastroesophageal cancer enhance ICI response in gastroesophageal cancer